ATOSSA THERAPEUTICS, INC. Payments To Acquire Equity Securities Fv Ni
ATOSSA THERAPEUTICS, INC. (ATOS) reported Payments To Acquire Equity Securities Fv Ni of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquitySecuritiesFvNi · last filed 2023-11-13
- 2023-09-30: Payments To Acquire Equity Securities Fv Ni 9 month $0.00.
- 2022-09-30: Payments To Acquire Equity Securities Fv Ni 9 month $2.70M.
- 2021-09-30: Payments To Acquire Equity Securities Fv Ni 9 month $0.00.
| Period end | Payments To Acquire Equity Securities Fv Ni 9 month |
|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2022-09-30 | $2.70M 10-Q · filed 2023-11-13 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |